2.21

0.45% +0.010

After Hours: 2.27 0.06 +2.71%

HeartBeam Inc (BEAT)

Overview News Price History Financials Discussions Forecast

HeartBeam Inc stock is currently priced at $2.21, with a 24-hour trading volume of 54,953. It has seen a +0.45% increased in the last 24 hours and a +5.74% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $2.20 pivot point. If it approaches the $2.25 resistance level, significant changes may occur.

Previous Close:

$2.20

Open:

$2.25

24h Volume:

54,953

Market Cap:

$58.19M

Revenue:

Net Income/Loss:

$-14.47M

P/E Ratio:

-1.4258

EPS:

-1.55

Net Cash Flow:

$-12.19M

1W Performance:

+10.50%

1M Performance:

+5.74%

6M Performance:

+66.17%

1Y Performance:

-4.33%

1D Range:

$2.06

$2.29

52W Range:

$1.06

$3.74

HeartBeam Inc Stock (BEAT) Company Profile

Name

HeartBeam Inc

Sector

Healthcare (1221)

Industry

Health Information Services (67)

Phone

408 899 4443

Address

2118 Walsh Avenue, Suite 210, Santa Clara

Employee

Twitter

Next Earnings Date

2024-05-09

Latest SEC Filings

BEAT's Discussions on Twitter

HeartBeam Inc Stock (BEAT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-11-20	Initiated	Needham	Buy
Sep-02-20	Initiated	Robert W. Baird	Neutral
Jan-08-20	Initiated	SunTrust	Buy
Aug-02-19	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-26-19	Reiterated	Dougherty & Company	Buy
Jul-26-18	Reiterated	Lake Street	Buy
Apr-26-18	Reiterated	The Benchmark Company	Buy
Feb-23-18	Reiterated	Dougherty & Company	Buy
Nov-08-17	Reiterated	Dougherty & Company	Buy
Oct-26-17	Initiated	Raymond James	Outperform
Oct-24-17	Initiated	SunTrust	Buy
Aug-09-17	Reiterated	Dougherty & Company	Buy
Jul-19-17	Reiterated	The Benchmark Company	Buy
Apr-11-17	Reiterated	Dougherty & Company	Buy
Dec-02-16	Initiated	Dougherty & Company	Buy
Sep-13-16	Initiated	Sidoti	Buy
Aug-03-16	Reiterated	The Benchmark Company	Buy
Jul-28-15	Reiterated	Dougherty & Company	Buy
Oct-24-13	Initiated	The Benchmark Company	Buy
Aug-21-13	Initiated	Dougherty & Company	Buy

View All

HeartBeam Inc Stock (BEAT) Latest News

Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Benzinga

HeartBeam Inc Stock (BEAT) Financials Data

HeartBeam Inc (BEAT) Net Income 2024

BEAT net income (TTM) was -$14.47 million for the quarter ending September 30, 2023, a -27.68% decrease year-over-year.

HeartBeam Inc (BEAT) Cash Flow 2024

BEAT recorded a free cash flow (TTM) of -$12.19 million for the quarter ending September 30, 2023, a -29.21% decrease year-over-year.

HeartBeam Inc (BEAT) Earnings per Share 2024

BEAT earnings per share (TTM) was -$1.24 for the quarter ending September 30, 2023, a +11.87% growth year-over-year.

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company develops three-dimensional (3D)-vector electrocardiogram (ECG) platform for heart attack detection. It is developing HeartBeam AIMI software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack; and HeartBeam AIMIGo, a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.